Watch CBS News

Remdesivir Trial: Patients Started Recovering By Day 15

CHICAGO (CBS) -- Patients on Remdesivir, a drug President Donald Trump was given for COVID-19, started recovering by day 15, according to a medical trial done in Chicago at Northwestern and the University of Illinois. That is faster than patients given a placebo.

However, it does not mean someone treated with the drug is out of the woods. The mortality rate on day 15 for people taking Remdesivir was 6.7%. That death rate nearly doubles for people who did not take it.

Serious side effects occurred in one out of four patients.

View CBS News In
CBS News App Open
Chrome Safari Continue
Be the first to know
Get browser notifications for breaking news, live events, and exclusive reporting.